| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 1.37e-04 | 6 | 61 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 2.54e-04 | 8 | 61 | 2 | GO:0032453 | |
| GeneOntologyBiologicalProcess | regulation of early endosome to late endosome transport | 2.71e-05 | 20 | 61 | 3 | GO:2000641 | |
| GeneOntologyBiologicalProcess | regulation of Golgi inheritance | 5.14e-05 | 4 | 61 | 2 | GO:0090170 | |
| GeneOntologyBiologicalProcess | regulation of telomere capping | 6.84e-05 | 27 | 61 | 3 | GO:1904353 | |
| GeneOntologyBiologicalProcess | organelle inheritance | 7.65e-05 | 28 | 61 | 3 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 7.65e-05 | 28 | 61 | 3 | GO:0048313 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomerase | 7.97e-05 | 77 | 61 | 4 | GO:0007004 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.07e-04 | 83 | 61 | 4 | GO:0006278 | |
| GeneOntologyBiologicalProcess | Golgi organization | 1.39e-04 | 168 | 61 | 5 | GO:0007030 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 1.46e-04 | 90 | 61 | 4 | GO:0010833 | |
| GeneOntologyBiologicalProcess | trachea formation | 1.79e-04 | 7 | 61 | 2 | GO:0060440 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage proliferation | 1.79e-04 | 7 | 61 | 2 | GO:0120041 | |
| GeneOntologyBiologicalProcess | metanephros development | 1.80e-04 | 95 | 61 | 4 | GO:0001656 | |
| GeneOntologyBiologicalProcess | peripheral nervous system development | 2.03e-04 | 98 | 61 | 4 | GO:0007422 | |
| GeneOntologyBiologicalProcess | regulation of macrophage proliferation | 2.38e-04 | 8 | 61 | 2 | GO:0120040 | |
| GeneOntologyBiologicalProcess | telomere capping | 2.42e-04 | 41 | 61 | 3 | GO:0016233 | |
| GeneOntologyBiologicalProcess | negative regulation of smoothened signaling pathway | 2.60e-04 | 42 | 61 | 3 | GO:0045879 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance | 3.39e-04 | 112 | 61 | 4 | GO:0032204 | |
| GeneOntologyBiologicalProcess | myelination | 3.58e-04 | 206 | 61 | 5 | GO:0042552 | |
| GeneOntologyBiologicalProcess | endosomal transport | 3.61e-04 | 320 | 61 | 6 | GO:0016197 | |
| GeneOntologyBiologicalProcess | Schwann cell development | 3.64e-04 | 47 | 61 | 3 | GO:0014044 | |
| GeneOntologyBiologicalProcess | outer ear morphogenesis | 3.81e-04 | 10 | 61 | 2 | GO:0042473 | |
| GeneOntologyBiologicalProcess | axon ensheathment | 3.82e-04 | 209 | 61 | 5 | GO:0008366 | |
| GeneOntologyBiologicalProcess | ensheathment of neurons | 3.82e-04 | 209 | 61 | 5 | GO:0007272 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 3.87e-04 | 48 | 61 | 3 | GO:0031281 | |
| GeneOntologyBiologicalProcess | early endosome to late endosome transport | 4.37e-04 | 50 | 61 | 3 | GO:0045022 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 4.63e-04 | 218 | 61 | 5 | GO:0071897 | |
| GeneOntologyBiologicalProcess | caveolin-mediated endocytosis | 5.57e-04 | 12 | 61 | 2 | GO:0072584 | |
| GeneOntologyBiologicalProcess | Bergmann glial cell differentiation | 5.57e-04 | 12 | 61 | 2 | GO:0060020 | |
| GeneOntologyBiologicalProcess | trachea morphogenesis | 5.57e-04 | 12 | 61 | 2 | GO:0060439 | |
| GeneOntologyBiologicalProcess | Schwann cell differentiation | 5.79e-04 | 55 | 61 | 3 | GO:0014037 | |
| GeneOntologyBiologicalProcess | maturation of SSU-rRNA | 5.79e-04 | 55 | 61 | 3 | GO:0030490 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport between endosomal compartments | 6.10e-04 | 56 | 61 | 3 | GO:0098927 | |
| GeneOntologyBiologicalProcess | macrophage proliferation | 6.57e-04 | 13 | 61 | 2 | GO:0061517 | |
| GeneOntologyBiologicalProcess | ERBB2-ERBB3 signaling pathway | 6.57e-04 | 13 | 61 | 2 | GO:0038133 | |
| GeneOntologyBiologicalProcess | regulation of DNA biosynthetic process | 7.45e-04 | 138 | 61 | 4 | GO:2000278 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomerase | 7.47e-04 | 60 | 61 | 3 | GO:0032210 | |
| GeneOntologyBiologicalProcess | ERBB3 signaling pathway | 7.65e-04 | 14 | 61 | 2 | GO:0038129 | |
| GeneOntologyBiologicalProcess | learning or memory | 8.07e-04 | 373 | 61 | 6 | GO:0007611 | |
| GeneOntologyBiologicalProcess | long-term synaptic potentiation | 8.73e-04 | 144 | 61 | 4 | GO:0060291 | |
| GeneOntologyBiologicalProcess | renal system development | 9.63e-04 | 386 | 61 | 6 | GO:0072001 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomere lengthening | 1.12e-03 | 69 | 61 | 3 | GO:1904356 | |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 1.12e-03 | 69 | 61 | 3 | GO:0031279 | |
| GeneOntologyBiologicalProcess | stress-activated protein kinase signaling cascade | 1.12e-03 | 69 | 61 | 3 | GO:0031098 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere capping | 1.14e-03 | 17 | 61 | 2 | GO:1904355 | |
| GeneOntologyBiologicalProcess | glial cell development | 1.20e-03 | 157 | 61 | 4 | GO:0021782 | |
| GeneOntologyBiologicalProcess | intracellular transport | DENND10 NF1 TRAF3IP1 XPO5 TMEM94 ITSN2 IFT122 MAPK1 MAPK3 BSN VPS53 VPS13B | 1.27e-03 | 1496 | 61 | 12 | GO:0046907 |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance | 1.27e-03 | 72 | 61 | 3 | GO:0032206 | |
| GeneOntologyBiologicalProcess | regulation of Golgi organization | 1.28e-03 | 18 | 61 | 2 | GO:1903358 | |
| GeneOntologyBiologicalProcess | endocrine system development | 1.32e-03 | 161 | 61 | 4 | GO:0035270 | |
| GeneOntologyBiologicalProcess | sensory organ development | 1.33e-03 | 730 | 61 | 8 | GO:0007423 | |
| GeneOntologyBiologicalProcess | short-term memory | 1.42e-03 | 19 | 61 | 2 | GO:0007614 | |
| GeneOntologyBiologicalProcess | cardiac neural crest cell differentiation involved in heart development | 1.42e-03 | 19 | 61 | 2 | GO:0061307 | |
| GeneOntologyBiologicalProcess | cardiac neural crest cell development involved in heart development | 1.42e-03 | 19 | 61 | 2 | GO:0061308 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | 1.45e-03 | 418 | 61 | 6 | GO:0070371 | |
| GeneOntologyBiologicalProcess | ear development | 1.54e-03 | 285 | 61 | 5 | GO:0043583 | |
| GeneOntologyBiologicalProcess | cognition | 1.54e-03 | 423 | 61 | 6 | GO:0050890 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 1.54e-03 | 168 | 61 | 4 | GO:0000723 | |
| GeneOntologyBiologicalProcess | intraciliary anterograde transport | 1.58e-03 | 20 | 61 | 2 | GO:0035720 | |
| GeneOntologyCellularComponent | t-UTP complex | 2.68e-05 | 3 | 63 | 2 | GO:0034455 | |
| GeneOntologyCellularComponent | trans-Golgi network | 3.16e-04 | 306 | 63 | 6 | GO:0005802 | |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 3.65e-04 | 112 | 63 | 4 | GO:0032588 | |
| GeneOntologyCellularComponent | ciliary base | 6.45e-04 | 56 | 63 | 3 | GO:0097546 | |
| HumanPheno | Hyperlordosis | 4.98e-05 | 222 | 24 | 7 | HP:0003307 | |
| HumanPheno | Lordosis | 4.98e-05 | 222 | 24 | 7 | HP:0002939 | |
| HumanPheno | Abnormal morphology of bones of the lower limbs | 7.15e-05 | 422 | 24 | 9 | HP:0040066 | |
| HumanPheno | Cubitus valgus | 9.52e-05 | 53 | 24 | 4 | HP:0002967 | |
| Domain | ARM-type_fold | 1.58e-07 | 339 | 62 | 10 | IPR016024 | |
| Domain | - | 6.84e-07 | 222 | 62 | 8 | 1.25.10.10 | |
| Domain | ARM-like | 2.96e-06 | 270 | 62 | 8 | IPR011989 | |
| Domain | MAPK_ERK1/2 | 1.08e-05 | 2 | 62 | 2 | IPR008349 | |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 3.25e-05 | 19 | 62 | 3 | IPR006553 | |
| Domain | LRR_CC | 3.25e-05 | 19 | 62 | 3 | SM00367 | |
| Domain | Lys_sp_deMease-like_dom | 6.48e-05 | 4 | 62 | 2 | IPR013637 | |
| Domain | PLU-1 | 6.48e-05 | 4 | 62 | 2 | PF08429 | |
| Domain | zf-C5HC2 | 1.08e-04 | 5 | 62 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 1.08e-04 | 5 | 62 | 2 | IPR004198 | |
| Domain | Znf_FYVE_PHD | 1.27e-04 | 147 | 62 | 5 | IPR011011 | |
| Domain | JmjN | 4.80e-04 | 10 | 62 | 2 | SM00545 | |
| Domain | JMJN | 4.80e-04 | 10 | 62 | 2 | PS51183 | |
| Domain | JmjN | 4.80e-04 | 10 | 62 | 2 | PF02375 | |
| Domain | JmjN | 4.80e-04 | 10 | 62 | 2 | IPR003349 | |
| Domain | - | 6.73e-04 | 321 | 62 | 6 | 3.80.10.10 | |
| Domain | MAP_kinase_CS | 7.00e-04 | 12 | 62 | 2 | IPR003527 | |
| Domain | MAPK | 7.00e-04 | 12 | 62 | 2 | PS01351 | |
| Domain | L_dom-like | 7.54e-04 | 328 | 62 | 6 | IPR032675 | |
| Domain | LRR_6 | 8.08e-04 | 55 | 62 | 3 | PF13516 | |
| Domain | - | 1.11e-03 | 15 | 62 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.11e-03 | 15 | 62 | 2 | SM00501 | |
| Domain | ARID_dom | 1.11e-03 | 15 | 62 | 2 | IPR001606 | |
| Domain | ARID | 1.11e-03 | 15 | 62 | 2 | PS51011 | |
| Domain | ARID | 1.11e-03 | 15 | 62 | 2 | PF01388 | |
| Domain | Zinc_finger_PHD-type_CS | 1.31e-03 | 65 | 62 | 3 | IPR019786 | |
| Domain | PHD | 1.98e-03 | 75 | 62 | 3 | PF00628 | |
| Domain | Leu-rich_rpt | 2.04e-03 | 271 | 62 | 5 | IPR001611 | |
| Domain | Znf_PHD-finger | 2.30e-03 | 79 | 62 | 3 | IPR019787 | |
| Domain | JmjC | 2.85e-03 | 24 | 62 | 2 | PF02373 | |
| Domain | PHD | 3.23e-03 | 89 | 62 | 3 | SM00249 | |
| Domain | Znf_PHD | 3.44e-03 | 91 | 62 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 3.88e-03 | 95 | 62 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 4.00e-03 | 96 | 62 | 3 | PS01359 | |
| Domain | ENTH_VHS | 4.16e-03 | 29 | 62 | 2 | IPR008942 | |
| Domain | JMJC | 5.04e-03 | 32 | 62 | 2 | PS51184 | |
| Domain | JmjC_dom | 5.04e-03 | 32 | 62 | 2 | IPR003347 | |
| Domain | JmjC | 5.36e-03 | 33 | 62 | 2 | SM00558 | |
| Domain | LRR_1 | 6.03e-03 | 219 | 62 | 4 | PF00560 | |
| Domain | - | 7.80e-03 | 40 | 62 | 2 | 3.40.630.30 | |
| Domain | F-box-like | 9.38e-03 | 44 | 62 | 2 | PF12937 | |
| Domain | Acyl_CoA_acyltransferase | 9.79e-03 | 45 | 62 | 2 | IPR016181 | |
| Pathway | PID_TELOMERASE_PATHWAY | 4.55e-05 | 67 | 42 | 4 | M105 | |
| Pathway | WP_THYROXINE_THYROID_HORMONE_PRODUCTION | 5.40e-05 | 25 | 42 | 3 | M39353 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 8.62e-05 | 5 | 42 | 2 | MM1575 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_USP8_TO_EGFR_ERK_ACTH_SIGNALING_PATHWAY | 8.62e-05 | 5 | 42 | 2 | M49028 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY | 8.62e-05 | 5 | 42 | 2 | M49016 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_ERK_SIGNALING_PATHWAY | 8.62e-05 | 5 | 42 | 2 | M49004 | |
| Pathway | WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER | 8.62e-05 | 5 | 42 | 2 | M39621 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.04e-04 | 31 | 42 | 3 | MM1343 | |
| Pathway | PID_SYNDECAN_2_PATHWAY | 1.26e-04 | 33 | 42 | 3 | M240 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.26e-04 | 33 | 42 | 3 | M6220 | |
| Pathway | BIOCARTA_SAM68_PATHWAY | 1.29e-04 | 6 | 42 | 2 | MM1567 | |
| Pathway | BIOCARTA_SAM68_PATHWAY | 1.29e-04 | 6 | 42 | 2 | M22052 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.29e-04 | 6 | 42 | 2 | M22062 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 1.29e-04 | 6 | 42 | 2 | M27559 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 1.29e-04 | 6 | 42 | 2 | MM15273 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 1.29e-04 | 6 | 42 | 2 | M47766 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING | 1.29e-04 | 6 | 42 | 2 | M47936 | |
| Pathway | REACTOME_SIGNALING_BY_NODAL | 1.29e-04 | 6 | 42 | 2 | MM14517 | |
| Pathway | REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS | 1.80e-04 | 7 | 42 | 2 | MM17070 | |
| Pathway | REACTOME_SIGNALING_BY_LTK_IN_CANCER | 1.80e-04 | 7 | 42 | 2 | M48255 | |
| Pathway | REACTOME_RSK_ACTIVATION | 1.80e-04 | 7 | 42 | 2 | M27369 | |
| Pathway | REACTOME_SUPPRESSION_OF_APOPTOSIS | 1.80e-04 | 7 | 42 | 2 | M29815 | |
| Pathway | BIOCARTA_STAT3_PATHWAY | 2.40e-04 | 8 | 42 | 2 | MM1576 | |
| Pathway | BIOCARTA_STAT3_PATHWAY | 2.40e-04 | 8 | 42 | 2 | M22063 | |
| Pathway | REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS | 2.40e-04 | 8 | 42 | 2 | M48010 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 2.40e-04 | 8 | 42 | 2 | M47642 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 2.40e-04 | 8 | 42 | 2 | M47643 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 3.08e-04 | 9 | 42 | 2 | M47641 | |
| Pathway | PID_PS1_PATHWAY | 3.41e-04 | 46 | 42 | 3 | M70 | |
| Pathway | REACTOME_SIGNAL_ATTENUATION | 3.84e-04 | 10 | 42 | 2 | M14236 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY | 3.84e-04 | 10 | 42 | 2 | M47374 | |
| Pathway | KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY | 3.84e-04 | 10 | 42 | 2 | M47420 | |
| Pathway | REACTOME_FORMATION_OF_APOPTOSOME | 3.84e-04 | 10 | 42 | 2 | MM14485 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 3.84e-04 | 10 | 42 | 2 | MM15135 | |
| Pathway | REACTOME_SIGNAL_ATTENUATION | 3.84e-04 | 10 | 42 | 2 | MM15440 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY | 3.84e-04 | 10 | 42 | 2 | M47735 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 3.84e-04 | 10 | 42 | 2 | M13962 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 4.37e-04 | 50 | 42 | 3 | M39822 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 4.69e-04 | 11 | 42 | 2 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 4.69e-04 | 11 | 42 | 2 | M47371 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 4.69e-04 | 11 | 42 | 2 | M48099 | |
| Pathway | REACTOME_FORMATION_OF_APOPTOSOME | 4.69e-04 | 11 | 42 | 2 | M41721 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 5.61e-04 | 12 | 42 | 2 | M47369 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY | 5.61e-04 | 12 | 42 | 2 | M47597 | |
| Pathway | REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION | 5.61e-04 | 12 | 42 | 2 | MM15036 | |
| Pathway | WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION | 5.61e-04 | 12 | 42 | 2 | M39802 | |
| Pathway | REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE | 5.61e-04 | 12 | 42 | 2 | MM14487 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 5.61e-04 | 12 | 42 | 2 | M47815 | |
| Pathway | REACTOME_ERKS_ARE_INACTIVATED | 6.62e-04 | 13 | 42 | 2 | MM14811 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 6.62e-04 | 13 | 42 | 2 | M47589 | |
| Pathway | REACTOME_ERKS_ARE_INACTIVATED | 6.62e-04 | 13 | 42 | 2 | M8410 | |
| Pathway | BIOCARTA_CDK5_PATHWAY | 6.62e-04 | 13 | 42 | 2 | M89 | |
| Pathway | REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE | 6.62e-04 | 13 | 42 | 2 | M26907 | |
| Pathway | WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS | 6.62e-04 | 13 | 42 | 2 | M39463 | |
| Pathway | WP_OSTEOPONTIN_SIGNALING | 6.62e-04 | 13 | 42 | 2 | M39603 | |
| Pathway | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | 6.62e-04 | 13 | 42 | 2 | M975 | |
| Pathway | PID_ATF2_PATHWAY | 7.12e-04 | 59 | 42 | 3 | M166 | |
| Pathway | REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL | 7.48e-04 | 60 | 42 | 3 | M27613 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 7.71e-04 | 14 | 42 | 2 | M668 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 7.71e-04 | 14 | 42 | 2 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 7.71e-04 | 14 | 42 | 2 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 7.71e-04 | 14 | 42 | 2 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 7.71e-04 | 14 | 42 | 2 | M47378 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY | 7.71e-04 | 14 | 42 | 2 | M47383 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY | 7.71e-04 | 14 | 42 | 2 | M47384 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 7.71e-04 | 14 | 42 | 2 | M622 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 7.71e-04 | 14 | 42 | 2 | MM14667 | |
| Pathway | BIOCARTA_CDK5_PATHWAY | 7.71e-04 | 14 | 42 | 2 | MM1457 | |
| Pathway | REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION | 7.71e-04 | 14 | 42 | 2 | M26983 | |
| Pathway | BIOCARTA_ERK5_PATHWAY | 7.71e-04 | 14 | 42 | 2 | MM1481 | |
| Pathway | PID_TCR_RAS_PATHWAY | 7.71e-04 | 14 | 42 | 2 | M134 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 7.71e-04 | 14 | 42 | 2 | M47488 | |
| Pathway | PID_S1P_S1P4_PATHWAY | 7.71e-04 | 14 | 42 | 2 | M64 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 7.71e-04 | 14 | 42 | 2 | MM1489 | |
| Pathway | BIOCARTA_ERK5_PATHWAY | 7.71e-04 | 14 | 42 | 2 | M16811 | |
| Pathway | BIOCARTA_CDMAC_PATHWAY | 8.88e-04 | 15 | 42 | 2 | MM1358 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47367 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47375 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47382 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47640 | |
| Pathway | PID_ARF6_DOWNSTREAM_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M120 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47531 | |
| Pathway | REACTOME_SIGNALING_BY_ACTIVIN | 8.88e-04 | 15 | 42 | 2 | MM14593 | |
| Pathway | PID_SMAD2_3PATHWAY | 1.01e-03 | 16 | 42 | 2 | M228 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.01e-03 | 16 | 42 | 2 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.01e-03 | 16 | 42 | 2 | M47373 | |
| Pathway | BIOCARTA_SPRY_PATHWAY | 1.01e-03 | 16 | 42 | 2 | MM1500 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 1.01e-03 | 16 | 42 | 2 | M47381 | |
| Pubmed | Neurofibromin (Nf1) is required for skeletal muscle development. | 5.10e-09 | 12 | 64 | 4 | 21478499 | |
| Pubmed | Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk. | 5.94e-09 | 3 | 64 | 3 | 23221339 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 14988395 | ||
| Pubmed | Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers. | 5.94e-09 | 3 | 64 | 3 | 14718391 | |
| Pubmed | ALOX15B controls macrophage cholesterol homeostasis via lipid peroxidation, ERK1/2 and SREBP2. | 2.37e-08 | 4 | 64 | 3 | 38581859 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 10627507 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 15125795 | ||
| Pubmed | 3.96e-08 | 19 | 64 | 4 | 25535838 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 21903164 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 28934393 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 12469121 | ||
| Pubmed | Depletion of skeletal muscle satellite cells attenuates pathology in muscular dystrophy. | 2.07e-07 | 7 | 64 | 3 | 35618700 | |
| Pubmed | 2.07e-07 | 7 | 64 | 3 | 16906226 | ||
| Pubmed | 3.31e-07 | 8 | 64 | 3 | 12115694 | ||
| Pubmed | Ablation of BRaf impairs neuronal differentiation in the postnatal hippocampus and cerebellum. | 4.95e-07 | 9 | 64 | 3 | 23505473 | |
| Pubmed | 4.95e-07 | 9 | 64 | 3 | 26460546 | ||
| Pubmed | Borealin/CDCA8 deficiency alters thyroid development and results in papillary tumor-like structures. | 7.07e-07 | 10 | 64 | 3 | 37964961 | |
| Pubmed | 7.07e-07 | 10 | 64 | 3 | 30348677 | ||
| Pubmed | 7.07e-07 | 10 | 64 | 3 | 18952847 | ||
| Pubmed | 1.29e-06 | 12 | 64 | 3 | 21289216 | ||
| Pubmed | Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. | 1.68e-06 | 13 | 64 | 3 | 18641643 | |
| Pubmed | Lens induction requires attenuation of ERK signaling by Nf1. | 1.68e-06 | 13 | 64 | 3 | 21233129 | |
| Pubmed | 1.68e-06 | 13 | 64 | 3 | 25574476 | ||
| Pubmed | Erk and MAPK signaling is essential for intestinal development through Wnt pathway modulation. | 1.75e-06 | 47 | 64 | 4 | 32747435 | |
| Pubmed | ERBB3-mediated regulation of Bergmann glia proliferation in cerebellar lamination. | 2.13e-06 | 14 | 64 | 3 | 25564653 | |
| Pubmed | 3.27e-06 | 16 | 64 | 3 | 38750011 | ||
| Pubmed | 3.27e-06 | 16 | 64 | 3 | 28637693 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 16796978 | ||
| Pubmed | Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein. | 3.33e-06 | 2 | 64 | 2 | 9792705 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 27564099 | ||
| Pubmed | A role for ERK2 in reconsolidation of fear memories in mice. | 3.33e-06 | 2 | 64 | 2 | 16504549 | |
| Pubmed | MEK1-ERK1/2 signaling regulates the cardiomyocyte non-sarcomeric actin cytoskeletal network. | 3.33e-06 | 2 | 64 | 2 | 37999644 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18070930 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18224451 | ||
| Pubmed | Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence. | 3.33e-06 | 2 | 64 | 2 | 23993963 | |
| Pubmed | Mechanical stress promotes angiogenesis through fibroblast exosomes. | 3.33e-06 | 2 | 64 | 2 | 32962863 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19801509 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 34316004 | ||
| Pubmed | Inhibition of the ERK pathway prevents HIVgp120-induced REM sleep increase. | 3.33e-06 | 2 | 64 | 2 | 11532249 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 28295277 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15456767 | ||
| Pubmed | Regulation of insulin gene transcription by ERK1 and ERK2 in pancreatic beta cells. | 3.33e-06 | 2 | 64 | 2 | 12810726 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12218045 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 29789577 | ||
| Pubmed | Bradykinin promotes neuron-generating division of neural progenitor cells through ERK activation. | 3.33e-06 | 2 | 64 | 2 | 27528403 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21705143 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 16081808 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15143154 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12555071 | ||
| Pubmed | ERK1/2 is related to oestrogen receptor and predicts outcome in hormone-treated breast cancer. | 3.33e-06 | 2 | 64 | 2 | 25085753 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20840867 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19286961 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19147767 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20716207 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21635820 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17709754 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 23643895 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 28986121 | ||
| Pubmed | Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers. | 3.33e-06 | 2 | 64 | 2 | 18055485 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 32444778 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15322023 | ||
| Pubmed | MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. | 3.33e-06 | 2 | 64 | 2 | 15096454 | |
| Pubmed | Both ERK1 and ERK2 are required for enterovirus 71 (EV71) efficient replication. | 3.33e-06 | 2 | 64 | 2 | 25803100 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20404333 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 14634064 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21248139 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 26566650 | ||
| Pubmed | [Effect of ERK1/2 signal pathway on the proliferation of lung fibroblast activated by SiOâ‚‚]. | 3.33e-06 | 2 | 64 | 2 | 21126445 | |
| Pubmed | Irradiation-induced G2/M checkpoint response requires ERK1/2 activation. | 3.33e-06 | 2 | 64 | 2 | 17297454 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15542825 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15721302 | ||
| Pubmed | Rapamycin inhibits Erk1/2-mediated neuronal apoptosis caused by cadmium. | 3.33e-06 | 2 | 64 | 2 | 26046303 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15059773 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17212589 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20540975 | ||
| Pubmed | Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx. | 3.33e-06 | 2 | 64 | 2 | 10441747 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 29188650 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20696763 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15132979 | ||
| Pubmed | Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus. | 3.33e-06 | 2 | 64 | 2 | 16416087 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19619605 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20368360 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21669399 | ||
| Pubmed | ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. | 3.33e-06 | 2 | 64 | 2 | 16805921 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 22269103 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19619936 | ||
| Pubmed | The role of erk1 and erk2 in multiple stages of T cell development. | 3.33e-06 | 2 | 64 | 2 | 16226508 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20453075 | ||
| Pubmed | Bovine colostrum promotes growth and migration of the human keratinocyte HaCaT cell line. | 3.33e-06 | 2 | 64 | 2 | 19919532 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18234473 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 26879318 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11789669 | ||
| Pubmed | ERK1/2 regulates two sequential steps promoting monocyte survival to peroxynitrite. | 3.33e-06 | 2 | 64 | 2 | 16998804 | |
| Pubmed | Dual roles of ERK1/2 in cellular senescence induced by excess thymidine in HeLa cells. | 3.33e-06 | 2 | 64 | 2 | 27443255 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 27613715 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18378312 | ||
| Pubmed | ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells. | 3.33e-06 | 2 | 64 | 2 | 23569008 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 22222560 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18164958 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19176891 | ||
| Interaction | GPR17 interactions | 2.40e-06 | 283 | 62 | 8 | int:GPR17 | |
| Interaction | VSIG2 interactions | 2.74e-06 | 32 | 62 | 4 | int:VSIG2 | |
| Interaction | FPR1 interactions | 5.97e-06 | 147 | 62 | 6 | int:FPR1 | |
| Interaction | CD40 interactions | 7.51e-06 | 153 | 62 | 6 | int:CD40 | |
| Interaction | EFNA4 interactions | 8.53e-06 | 239 | 62 | 7 | int:EFNA4 | |
| Interaction | GPR182 interactions | 9.89e-06 | 455 | 62 | 9 | int:GPR182 | |
| Interaction | CD70 interactions | 1.20e-05 | 166 | 62 | 6 | int:CD70 | |
| Interaction | P2RY8 interactions | 1.84e-05 | 179 | 62 | 6 | int:P2RY8 | |
| Interaction | P2RY10 interactions | 1.87e-05 | 106 | 62 | 5 | int:P2RY10 | |
| Interaction | F2RL1 interactions | 2.02e-05 | 182 | 62 | 6 | int:F2RL1 | |
| Interaction | SIGLECL1 interactions | 2.54e-05 | 113 | 62 | 5 | int:SIGLECL1 | |
| Interaction | PROKR1 interactions | 3.54e-05 | 21 | 62 | 3 | int:PROKR1 | |
| Interaction | HCST interactions | 3.94e-05 | 205 | 62 | 6 | int:HCST | |
| Interaction | TRIM16 interactions | 3.96e-05 | 62 | 62 | 4 | int:TRIM16 | |
| Interaction | TPST2 interactions | 3.98e-05 | 124 | 62 | 5 | int:TPST2 | |
| Interaction | LINC01588 interactions | 4.10e-05 | 22 | 62 | 3 | int:LINC01588 | |
| Interaction | FAM234A interactions | 4.29e-05 | 126 | 62 | 5 | int:FAM234A | |
| Interaction | OPALIN interactions | 4.39e-05 | 209 | 62 | 6 | int:OPALIN | |
| Interaction | IGHM interactions | 4.98e-05 | 130 | 62 | 5 | int:IGHM | |
| Interaction | KLHL14 interactions | 5.07e-05 | 66 | 62 | 4 | int:KLHL14 | |
| Interaction | C4orf36 interactions | 5.57e-05 | 4 | 62 | 2 | int:C4orf36 | |
| Interaction | MGARP interactions | 6.14e-05 | 222 | 62 | 6 | int:MGARP | |
| Interaction | MFSD4A interactions | 6.61e-05 | 225 | 62 | 6 | int:MFSD4A | |
| Interaction | EFNB1 interactions | 1.31e-04 | 255 | 62 | 6 | int:EFNB1 | |
| Interaction | TRRAP interactions | 1.37e-04 | 790 | 62 | 10 | int:TRRAP | |
| Interaction | ZUP1 interactions | 1.97e-04 | 174 | 62 | 5 | int:ZUP1 | |
| Interaction | PAGE1 interactions | 2.00e-04 | 37 | 62 | 3 | int:PAGE1 | |
| Interaction | NPTN interactions | 2.10e-04 | 278 | 62 | 6 | int:NPTN | |
| Interaction | DGCR2 interactions | 2.36e-04 | 181 | 62 | 5 | int:DGCR2 | |
| Interaction | GPR45 interactions | 3.16e-04 | 300 | 62 | 6 | int:GPR45 | |
| Interaction | VIPR2 interactions | 3.26e-04 | 194 | 62 | 5 | int:VIPR2 | |
| Interaction | DENND10P1 interactions | 3.31e-04 | 9 | 62 | 2 | int:DENND10P1 | |
| Interaction | STAB2 interactions | 3.31e-04 | 9 | 62 | 2 | int:STAB2 | |
| Interaction | TATDN3 interactions | 3.31e-04 | 9 | 62 | 2 | int:TATDN3 | |
| Interaction | IRX2 interactions | 3.31e-04 | 9 | 62 | 2 | int:IRX2 | |
| Interaction | VPS52 interactions | 3.33e-04 | 195 | 62 | 5 | int:VPS52 | |
| Interaction | COMTD1 interactions | 3.74e-04 | 200 | 62 | 5 | int:COMTD1 | |
| Interaction | SGCA interactions | 4.07e-04 | 113 | 62 | 4 | int:SGCA | |
| Interaction | VIPR1 interactions | 4.19e-04 | 205 | 62 | 5 | int:VIPR1 | |
| Interaction | C3orf18 interactions | 4.35e-04 | 115 | 62 | 4 | int:C3orf18 | |
| Interaction | SOS1 interactions | 4.64e-04 | 117 | 62 | 4 | int:SOS1 | |
| Interaction | TNFSF13B interactions | 4.95e-04 | 119 | 62 | 4 | int:TNFSF13B | |
| Interaction | ZCCHC4 interactions | 5.03e-04 | 11 | 62 | 2 | int:ZCCHC4 | |
| Cytoband | 10q23.33 | 4.28e-06 | 23 | 63 | 3 | 10q23.33 | |
| Cytoband | 12p13.33 | 3.12e-04 | 19 | 63 | 2 | 12p13.33 | |
| GeneFamily | ZYG11 cell cycle regulator family | 1.58e-05 | 3 | 42 | 2 | 6 | |
| GeneFamily | Mitogen-activated protein kinases | 4.04e-04 | 13 | 42 | 2 | 651 | |
| GeneFamily | AT-rich interaction domain containing | 5.43e-04 | 15 | 42 | 2 | 418 | |
| GeneFamily | F-box and leucine rich repeat proteins | 1.08e-03 | 21 | 42 | 2 | 558 | |
| GeneFamily | PHD finger proteins | 1.19e-03 | 90 | 42 | 3 | 88 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 1.41e-03 | 24 | 42 | 2 | 615 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.41e-03 | 24 | 42 | 2 | 485 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 6.25e-03 | 51 | 42 | 2 | 870 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 6.73e-03 | 53 | 42 | 2 | 103 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN | 7.50e-06 | 195 | 63 | 6 | M7410 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.08e-06 | 243 | 61 | 7 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-07 | 174 | 62 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.47e-07 | 199 | 62 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.49e-06 | 199 | 62 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| Drug | Phenylthiourea | 4.89e-08 | 14 | 62 | 4 | ctd:D010670 | |
| Drug | NIH-3 | 1.87e-07 | 19 | 62 | 4 | CID009822007 | |
| Drug | AG 127 | 7.30e-06 | 2 | 62 | 2 | ctd:C069028 | |
| Drug | N-acetyl glycine cysteine amide | 7.30e-06 | 2 | 62 | 2 | ctd:C510898 | |
| Drug | N-acetyl-Cys-Gly-Pro-Cys-amide | 7.30e-06 | 2 | 62 | 2 | ctd:C510899 | |
| Drug | NF023 | 7.30e-06 | 2 | 62 | 2 | ctd:C105374 | |
| Drug | tyrphostin 51 | 7.30e-06 | 2 | 62 | 2 | ctd:C118515 | |
| Drug | cysteinyl-leukotriene | 7.30e-06 | 2 | 62 | 2 | ctd:C112381 | |
| Drug | NP00111 | 7.30e-06 | 2 | 62 | 2 | ctd:C530042 | |
| Drug | substance P (6-11), Tyr(6)-D-Phe(7)-D-His(9)- | 7.30e-06 | 2 | 62 | 2 | ctd:C496429 | |
| Drug | 7-methyljuglone | 7.30e-06 | 2 | 62 | 2 | ctd:C517013 | |
| Drug | sodium tetrasulfide | 7.30e-06 | 2 | 62 | 2 | ctd:C519323 | |
| Drug | L 759656 | 7.30e-06 | 2 | 62 | 2 | ctd:C118949 | |
| Drug | 2,2',4,4',5,5'-hexabrominated diphenyl ether | 7.30e-06 | 2 | 62 | 2 | ctd:C478854 | |
| Drug | CGP 56999A | 7.30e-06 | 2 | 62 | 2 | ctd:C102659 | |
| Drug | L 709049 | 8.55e-06 | 15 | 62 | 3 | ctd:C096429 | |
| Drug | Sulfanilamide [63-74-1]; Up 200; 23.2uM; HL60; HT_HG-U133A | 1.69e-05 | 199 | 62 | 6 | 2709_UP | |
| Drug | Pyridazines | 2.18e-05 | 3 | 62 | 2 | ctd:D011724 | |
| Drug | 3,5-diiodothyropropionic acid | 2.18e-05 | 3 | 62 | 2 | ctd:C082182 | |
| Drug | PQ 401 | 2.18e-05 | 3 | 62 | 2 | ctd:C569479 | |
| Drug | SB 258585 | 2.18e-05 | 3 | 62 | 2 | ctd:C418570 | |
| Drug | cassine | 2.18e-05 | 3 | 62 | 2 | ctd:C426663 | |
| Drug | manganese(III) acetate dihydrate | 2.18e-05 | 3 | 62 | 2 | ctd:C521134 | |
| Drug | Nipaam-ntbam copolymer | 2.18e-05 | 3 | 62 | 2 | CID003080965 | |
| Drug | connective tissue-activating peptide | 2.18e-05 | 3 | 62 | 2 | ctd:C009862 | |
| Drug | spectaline | 2.18e-05 | 3 | 62 | 2 | ctd:C480880 | |
| Drug | delta(4)-tibolone | 2.18e-05 | 3 | 62 | 2 | ctd:C485706 | |
| Drug | p38alpha inhibitor CMPD1 | 2.18e-05 | 3 | 62 | 2 | ctd:C492719 | |
| Drug | OR486 | 2.18e-05 | 3 | 62 | 2 | ctd:C057726 | |
| Drug | GW2974 | 2.18e-05 | 3 | 62 | 2 | ctd:C506645 | |
| Drug | kaempferol-7-methyl ether | 2.18e-05 | 3 | 62 | 2 | ctd:C541117 | |
| Drug | tPA stop | 2.18e-05 | 3 | 62 | 2 | ctd:C115645 | |
| Drug | LBT 613 | 2.18e-05 | 3 | 62 | 2 | ctd:C514877 | |
| Drug | AAL 881 | 2.18e-05 | 3 | 62 | 2 | ctd:C514876 | |
| Drug | NGB 2904 | 2.18e-05 | 3 | 62 | 2 | ctd:C116818 | |
| Drug | wogonoside | 2.18e-05 | 3 | 62 | 2 | ctd:C473995 | |
| Drug | Ginkgolides | 2.18e-05 | 3 | 62 | 2 | ctd:D046934 | |
| Drug | 19-epi-okadaic acid | 2.18e-05 | 3 | 62 | 2 | ctd:C522300 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 2.18e-05 | 3 | 62 | 2 | ctd:C079694 | |
| Drug | 5-chloro-2-methyl-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole | 2.18e-05 | 3 | 62 | 2 | ctd:C534240 | |
| Drug | YM-254890 | 2.18e-05 | 3 | 62 | 2 | ctd:C475455 | |
| Drug | poly(N-isopropylacrylamide-N-tert-butylacrylamide)copolymer | 2.18e-05 | 3 | 62 | 2 | ctd:C079805 | |
| Drug | capsanthin | 2.18e-05 | 3 | 62 | 2 | ctd:C006889 | |
| Drug | hispidulin | 2.18e-05 | 3 | 62 | 2 | ctd:C055957 | |
| Drug | bromoxynil octanoate | 2.18e-05 | 3 | 62 | 2 | ctd:C028382 | |
| Drug | ML 204 | 2.18e-05 | 3 | 62 | 2 | ctd:C567966 | |
| Drug | hwanggunchungyitang | 2.18e-05 | 3 | 62 | 2 | ctd:C539018 | |
| Drug | BPC96 peptide | 2.18e-05 | 3 | 62 | 2 | ctd:C555919 | |
| Drug | N,N''-1,4-butanediylbis(N'-(3-isothiocyanatophenyl))thiourea | 2.18e-05 | 3 | 62 | 2 | ctd:C541384 | |
| Drug | Phosphatidylinositols | 3.28e-05 | 23 | 62 | 3 | ctd:D010716 | |
| Drug | isosalipurposide | 4.36e-05 | 4 | 62 | 2 | ctd:C027321 | |
| Drug | diacetylbis(4-methylthiosemicarbazonato)copper(II) | 4.36e-05 | 4 | 62 | 2 | ctd:C570445 | |
| Drug | neurotropin | 4.36e-05 | 4 | 62 | 2 | ctd:C010491 | |
| Drug | N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide | 4.36e-05 | 4 | 62 | 2 | ctd:C481448 | |
| Drug | 2-(2-oxo-2-((3,7,11-trimethyl-2,6,10-dodecatrienyl)oxy)aminoethyl)phosphonic acid, (2,2-dimethyl-1-oxopropoxy)methyl ester sodium | 4.36e-05 | 4 | 62 | 2 | ctd:C436083 | |
| Drug | 2,3,4,2',3',4'-hexachlorobiphenyl | 4.36e-05 | 4 | 62 | 2 | ctd:C014218 | |
| Drug | 3-(phenylsulfonyl)-4-(2-(4-(2-(3,7,11-trimethyldodeca-2,6,10-trienylthio)benzoyl)piperazin-1-yl)ethoxy)-1,2,5-oxadiazole-2-oxide | 4.36e-05 | 4 | 62 | 2 | ctd:C559860 | |
| Drug | Purvalanol | 4.36e-05 | 4 | 62 | 2 | DB02733 | |
| Drug | azalanstat | 4.36e-05 | 4 | 62 | 2 | ctd:C082410 | |
| Drug | Practolol | 4.36e-05 | 4 | 62 | 2 | ctd:D011217 | |
| Drug | Dmt-NMe-Ala-Aba-Gly-NH2 | 4.36e-05 | 4 | 62 | 2 | ctd:C569763 | |
| Drug | methyl 3, 5-O-dicaffeoylquinate | 4.36e-05 | 4 | 62 | 2 | ctd:C538691 | |
| Drug | 1,4,5,8-naphthalenetetracarboxylic diimide | 4.36e-05 | 4 | 62 | 2 | ctd:C429685 | |
| Drug | O(2)-(2,4-dinitrophenyl) 1-(4-(N,N-diethylcarboxamido)piperazin-1-yl)diazen-1-ium 1,2-diolate | 4.36e-05 | 4 | 62 | 2 | ctd:C495194 | |
| Drug | 3-(4-Amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridine | 4.36e-05 | 4 | 62 | 2 | ctd:C423582 | |
| Drug | mitonafide | 4.36e-05 | 4 | 62 | 2 | ctd:C019215 | |
| Drug | 4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate) | 4.36e-05 | 4 | 62 | 2 | ctd:C110258 | |
| Drug | thunberginol A | 4.36e-05 | 4 | 62 | 2 | ctd:C079055 | |
| Drug | 7-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl ester | 4.36e-05 | 4 | 62 | 2 | ctd:C117789 | |
| Drug | phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide | 4.36e-05 | 4 | 62 | 2 | ctd:C049352 | |
| Drug | amosulalol | 4.36e-05 | 4 | 62 | 2 | ctd:C032473 | |
| Drug | 1-propyl-5-(3-p-tolylisoxazol-5-yl)-1,2,3,6-tetrahydropyridine | 4.36e-05 | 4 | 62 | 2 | ctd:C107238 | |
| Drug | erigeroflavanone | 4.36e-05 | 4 | 62 | 2 | ctd:C529414 | |
| Drug | JTE 907 | 4.36e-05 | 4 | 62 | 2 | ctd:C422645 | |
| Drug | PD 166285 | 4.36e-05 | 4 | 62 | 2 | ctd:C109647 | |
| Drug | 2,5,3'-trichlorobiphenyl | 4.36e-05 | 4 | 62 | 2 | ctd:C091160 | |
| Drug | trimethyltin hydroxide | 4.36e-05 | 4 | 62 | 2 | ctd:C037718 | |
| Drug | bovine serum albumin-corticosterone conjugate | 4.36e-05 | 4 | 62 | 2 | ctd:C439264 | |
| Drug | Imines | 4.36e-05 | 4 | 62 | 2 | ctd:D007097 | |
| Drug | 3',4'-dihydroxy-4-monochlorobiphenyl | 4.36e-05 | 4 | 62 | 2 | ctd:C543847 | |
| Drug | pamoic acid | 4.36e-05 | 4 | 62 | 2 | ctd:C004368 | |
| Drug | corticosterone-21-hemisuccinate | 4.36e-05 | 4 | 62 | 2 | ctd:C067957 | |
| Drug | ado-trastuzumab emtansine | 4.36e-05 | 4 | 62 | 2 | ctd:C550911 | |
| Drug | Thiorphan | 7.26e-05 | 5 | 62 | 2 | ctd:D015244 | |
| Drug | WHI P154 | 7.26e-05 | 5 | 62 | 2 | ctd:C113888 | |
| Drug | piplartine | 7.26e-05 | 5 | 62 | 2 | ctd:C479506 | |
| Drug | GGTI-2133 | 7.26e-05 | 5 | 62 | 2 | ctd:C547856 | |
| Drug | SR140333B | 7.26e-05 | 5 | 62 | 2 | ctd:C526005 | |
| Drug | CP 154526 | 7.26e-05 | 5 | 62 | 2 | ctd:C101628 | |
| Drug | 5-iodo-3-(2-azetidinylmethoxy)pyridine | 7.26e-05 | 5 | 62 | 2 | ctd:C426745 | |
| Drug | ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate | 7.26e-05 | 5 | 62 | 2 | ctd:C559943 | |
| Drug | Zeaxanthins | 7.26e-05 | 5 | 62 | 2 | ctd:D065146 | |
| Drug | 6,7-dimethoxy-2-phenylquinoxaline | 7.26e-05 | 5 | 62 | 2 | ctd:C407689 | |
| Drug | Thiamylal | 7.26e-05 | 5 | 62 | 2 | ctd:D013840 | |
| Drug | E 3330 | 7.26e-05 | 5 | 62 | 2 | ctd:C075569 | |
| Drug | tyrphostin AG825 | 7.26e-05 | 5 | 62 | 2 | ctd:C098214 | |
| Drug | Vitamin U | 7.26e-05 | 5 | 62 | 2 | ctd:D014814 | |
| Drug | ciproxifan | 7.26e-05 | 5 | 62 | 2 | ctd:C115705 | |
| Drug | ilomastat | 7.26e-05 | 5 | 62 | 2 | ctd:C119203 | |
| Drug | Bacterial Toxins | 7.26e-05 | 5 | 62 | 2 | ctd:D001427 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.69e-05 | 75 | 60 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 2.43e-05 | 4 | 60 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | Hypothyroidism | 2.43e-05 | 4 | 60 | 2 | C0020676 | |
| Disease | CEROID LIPOFUSCINOSIS, NEURONAL, 6 | 6.07e-05 | 6 | 60 | 2 | C1866282 | |
| Disease | Streptococcal pneumonia | 6.07e-05 | 6 | 60 | 2 | C0155862 | |
| Disease | endometrial adenocarcinoma (is_implicated_in) | 8.48e-05 | 7 | 60 | 2 | DOID:2870 (is_implicated_in) | |
| Disease | ureteral obstruction (implicated_via_orthology) | 1.45e-04 | 9 | 60 | 2 | DOID:5199 (implicated_via_orthology) | |
| Disease | endometrial adenocarcinoma (is_marker_for) | 2.21e-04 | 11 | 60 | 2 | DOID:2870 (is_marker_for) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.64e-04 | 152 | 60 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Trigeminal Neuralgia | 2.65e-04 | 12 | 60 | 2 | C0040997 | |
| Disease | Secondary Trigeminal Neuralgia | 2.65e-04 | 12 | 60 | 2 | C0393787 | |
| Disease | Trigeminal Neuralgia, Idiopathic | 2.65e-04 | 12 | 60 | 2 | C0393786 | |
| Disease | liver cirrhosis (implicated_via_orthology) | 3.13e-04 | 13 | 60 | 2 | DOID:5082 (implicated_via_orthology) | |
| Disease | gastric ulcer (implicated_via_orthology) | 3.64e-04 | 14 | 60 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 3.64e-04 | 14 | 60 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | Cardiomyopathies, Primary | 3.81e-04 | 69 | 60 | 3 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 3.81e-04 | 69 | 60 | 3 | C0036529 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 4.79e-04 | 16 | 60 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | pancreatic ductal carcinoma (is_implicated_in) | 4.79e-04 | 16 | 60 | 2 | DOID:3587 (is_implicated_in) | |
| Disease | Astrocytosis | 5.42e-04 | 17 | 60 | 2 | C3887640 | |
| Disease | Gliosis | 5.42e-04 | 17 | 60 | 2 | C0017639 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 6.09e-04 | 18 | 60 | 2 | HP_0002373 | |
| Disease | Hypertrophy | 6.09e-04 | 18 | 60 | 2 | C0020564 | |
| Disease | monocyte percentage of leukocytes | 6.88e-04 | 731 | 60 | 7 | EFO_0007989 | |
| Disease | Neoplasm Metastasis | 1.01e-03 | 217 | 60 | 4 | C0027627 | |
| Disease | Septicemia | 1.09e-03 | 24 | 60 | 2 | C0036690 | |
| Disease | Sepsis | 1.09e-03 | 24 | 60 | 2 | C0243026 | |
| Disease | Severe Sepsis | 1.09e-03 | 24 | 60 | 2 | C1719672 | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 1.09e-03 | 24 | 60 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | Head Neoplasms | 1.09e-03 | 24 | 60 | 2 | C0018675 | |
| Disease | Upper Aerodigestive Tract Neoplasms | 1.09e-03 | 24 | 60 | 2 | C0887900 | |
| Disease | Pyemia | 1.09e-03 | 24 | 60 | 2 | C0034189 | |
| Disease | Cancer of Head | 1.09e-03 | 24 | 60 | 2 | C0751177 | |
| Disease | obesity (is_marker_for) | 1.16e-03 | 101 | 60 | 3 | DOID:9970 (is_marker_for) | |
| Disease | Neck Neoplasms | 1.18e-03 | 25 | 60 | 2 | C0027533 | |
| Disease | Cancer of Neck | 1.18e-03 | 25 | 60 | 2 | C0746787 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.28e-03 | 26 | 60 | 2 | DOID:234 (is_implicated_in) | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.29e-03 | 105 | 60 | 3 | DOID:9352 (implicated_via_orthology) | |
| Disease | multiple sclerosis | 1.29e-03 | 594 | 60 | 6 | MONDO_0005301 | |
| Disease | eye measurement | 1.38e-03 | 27 | 60 | 2 | EFO_0004731 | |
| Disease | Subfertility, Female | 1.49e-03 | 28 | 60 | 2 | C0341869 | |
| Disease | Sterility, Postpartum | 1.49e-03 | 28 | 60 | 2 | C0038279 | |
| Disease | Female sterility | 1.49e-03 | 28 | 60 | 2 | C0917730 | |
| Disease | Female infertility | 1.49e-03 | 28 | 60 | 2 | C0021361 | |
| Disease | pulmonary hypertension (is_implicated_in) | 1.71e-03 | 30 | 60 | 2 | DOID:6432 (is_implicated_in) | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 1.71e-03 | 30 | 60 | 2 | C1868672 | |
| Disease | Cholestasis, Extrahepatic | 1.94e-03 | 32 | 60 | 2 | C0005398 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LQCSKCRLQFLTLKE | 451 | P59817 | |
| RSLKLCLLCQDKNFL | 236 | Q8WW43 | |
| NLLLRKCCLTDENKL | 41 | Q6NSW5 | |
| LFELSCIINRCKLDV | 1386 | Q9Y6D6 | |
| LALLVLSLILCNQCR | 4516 | Q6V0I7 | |
| ELLACLLDQTNLCRL | 136 | P09681 | |
| QKALCLDLLSLSAAC | 3116 | P11532 | |
| LIIRLALAETFCLNC | 1211 | Q92878 | |
| QCLLSLLSCLNNLFL | 631 | Q9NZM3 | |
| LLNTTCDLKICDFGL | 156 | P28482 | |
| IYCQNLCLLAKLFLD | 416 | O95251 | |
| ELLQIIGKCCLNKLS | 106 | Q8TDR0 | |
| IILCQEKRLQCLSFS | 446 | Q9HBG6 | |
| ILLSFIRCLQANLLC | 56 | Q71F56 | |
| VVLQNCRCLDLLFLS | 501 | P61550 | |
| HELLCSLQKQLLAFC | 986 | Q15751 | |
| LLQRLKNCLSEVEAC | 801 | Q9BY66 | |
| LCLNCQTKRLLEGSL | 511 | Q9UPA5 | |
| VKLRLCQECSIKLNF | 206 | Q70Z53 | |
| CLVLNLFCADLLFIS | 76 | Q5NUL3 | |
| LITCLLCVSQKQFFL | 316 | O94915 | |
| NLLINTTCDLKICDF | 171 | P27361 | |
| KACGLLNCEAVLQLL | 271 | Q96N21 | |
| KLRLVCLAAFILQKC | 491 | Q9H8H2 | |
| CLGLEQLTLQDCQKL | 201 | Q8N1E6 | |
| LNDLLCLDCLNITRI | 481 | Q9H0A0 | |
| CCLGQKQLAILLSLV | 1361 | Q86WI3 | |
| LCKTLQRDCLVLQSF | 251 | A2A3N6 | |
| QCLKDISLFLLLCNV | 491 | Q7RTS6 | |
| AANLLQIKLVLKECC | 111 | Q9NXS3 | |
| CLKGALIKTQLCVLF | 261 | Q9UG22 | |
| LIKTQLCVLFCIQLF | 266 | Q9UG22 | |
| ALFIICCLLKVFICQ | 106 | Q7RTS9 | |
| ECLALNCFNLKRLSL | 421 | Q9UJT9 | |
| ENFLLLFRCQQLKSC | 86 | P05937 | |
| DLRNQICFQLLTLCL | 341 | Q96D53 | |
| LVLTLLCDACQKVYL | 21 | Q08554 | |
| TKQLILSCLLNICQK | 1251 | Q9H583 | |
| NLLLRKCCLTDENKL | 41 | Q8TCE6 | |
| LLMFLDICSELNKLC | 66 | Q96E40 | |
| KHIALLLFTNCILNC | 766 | O75473 | |
| CLGLQTLLSLKCCID | 241 | Q9BQI9 | |
| KRQALSNSDCVLLCL | 46 | P59533 | |
| CLISCSKKRQLLLFQ | 336 | Q969X6 | |
| QICSLLKKLFCRIQE | 681 | Q6YHU6 | |
| DILFLLTCCLNRSAK | 1461 | Q6YHU6 | |
| LLVCTFLVCALLLLN | 971 | Q9Y6C5 | |
| RLCGCLELLLQFDQK | 41 | Q6ZNE9 | |
| QLLVCNCIFKNTLAI | 601 | P49221 | |
| RVIINLFLCCLLNLQ | 356 | O94827 | |
| LFLCCLLNLQESGLL | 361 | O94827 | |
| LEQKDLLLLCNSPCI | 391 | Q6XR72 | |
| KNCLLSLCSDRILQD | 426 | Q9C0D3 | |
| LKLAFCLALCAKLEQ | 86 | Q9H2L4 | |
| KCFLFLLQCQLTLVV | 1091 | Q12767 | |
| LLLYKCSECSQLFQL | 211 | Q6ZN55 | |
| RILLCVLTFLCLSFN | 481 | Q12772 | |
| ENCKLLEILCLLLNE | 246 | Q9HAV4 | |
| LLCALTCTFNLKIEG | 1876 | P21359 | |
| VAKFTLEELCLICNI | 541 | Q5VIR6 | |
| SNFLELICQVLRKAC | 181 | Q9P2E3 | |
| IQFLAQADCKLLECR | 2546 | Q7Z7G8 | |
| KLCFCPLAVLLQALL | 1476 | Q6PGP7 | |
| EKLVLSLCCNNLSLP | 1051 | O15016 | |
| ACLSFCQLQKQQILL | 91 | P01266 | |
| ICLNVLIANLEKLCS | 41 | Q6WRX3 | |
| KIAALKCLQVLLLQC | 171 | O43156 | |
| LLQQLKNCLSEAEAC | 811 | P41229 |